Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D

Biochemical and Biophysical Research Communications

Volumn 401, Issue 4, 2010, Pages 498-503

  Zhang, Yanfeng ^a   Buchko, Garry W ^a   Qin, Ling ^b   Robinson, Howard ^c   Varnum, Susan M ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b SANDIA NATIONAL LABORATORIES   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Botulinum neurotoxin D; Botulism; Crystal structure; Gangliosides; Phosphatidylethanolamine

Indexed keywords

BOTULINUM NEUROTOXIN D; BOTULINUM TOXIN; GANGLIOSIDE; LIPOSOME; MEMBRANE LIPID; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; RECEPTOR BINDING; SEROTYPE;

BINDING SITES; BOTULINUM TOXINS; CARRIER PROTEINS; CRYSTALLOGRAPHY, X-RAY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 77958482883     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.063     Document Type: Article

References (32)

1. Lamanna C. The most poisonous poison. Science 1959, 130:763-772.
2. Habermann E., Dreyer F. Clostridial neurotoxins: handling and action at the cellular and molecular level. Curr. Top. Microbiol. Immunol. 1986, 129:93-179.
3. Takeda M., Tsukamoto K., Kohda T., Matsui M., Mukamoto M., Kozaki S. Characterization of the neurotoxin produced by isolates associated with avian botulism. Avian Dis. 2005, 49:376-381.
4. DasGupta B.R., Sugiyama H. A common subunit structure in Clostridium botulinum type A, B and E toxins. Biochem. Biophys. Res. Commun. 1972, 48:108-112.
5. Montal M. Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 2010, 79:591-617.
6. Breidenbach M.A., Brunger A.T. New insights into clostridial neurotoxin-SNARE interactions. Trends Mol. Med. 2005, 11:377-381.
7. Tonello F., Morante S., Rossetto O., Schiavo G., Montecucco C. Tetanus and botulism neurotoxins: a novel group of zinc-endopeptidases. Adv. Exp. Med. Biol. 1996, 389:251-260.
8. Montecucco C., Schiavo G., Pantano S. SNARE complexes and neuroexocytosis: how many, how close?. Trends Biochem. Sci. 2005, 30:367-372.
9. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80:717-766.
10. Montecucco C. Double receptors for tetanus and botulinum toxins. Eur. J. Cell Biol. 1986, 42. 13-13.
11. Montecucco C. How do tetanus and botulinum toxins bind to neuronal membranes. Trends Biochem. Sci. 1986, 11:314-317.
12. Rummel A., Karnath T., Henke T., Bigalke H., Binz T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 2004, 279:30865-30870.
13. Dong M., Richards D.A., Goodnough M.C., Tepp W.H., Johnson E.A., Chapman E.R. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 2003, 162:1293-1303.
14. Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., Chapman E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006, 312:592-596.
15. Mahrhold S., Rummel A., Bigalke H., Davletov B., Binz T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 2006, 580:2011-2014.
16. Dong M., Liu H.S., Tepp W.H., Johnson E.A., Janz R., Chapman E.R. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol. Biol. Cell 2008, 19:5226-5237.
17. Rummel A., Hafner K., Mahrhold S., Darashchonak N., Holt M., Jahn R., Beermann S., Karnath T., Bigalke H., Binz T. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J. Neurochem. 2009, 110:1942-1954.
18. Tsukamoto K., Kohda T., Mukamoto M., Takeuchi K., Ihara H., Saito M., Kozaki S. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J. Biol. Chem. 2005, 280:35164-35171.
19. Tsukamoto K., Kozai Y., Ihara H., Kohda T., Mukamoto M., Tsuji T., Kozaki S. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D. Microb. Pathog. 2008, 44:484-493.
20. Fu Z., Chen C., Barbieri J.T., Kim J.J., Baldwin M.R. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 2009, 48:5631-5641.
21. Stenmark P., Dong M., Dupuy J., Chapman E.R., Stevens R.C. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding. J. Mol. Biol. 2010, 397:1287-1297.
22. Schmitt J., Karalewitz A., Benefield D.A., Mushrush D.J., Pruitt R.N., Spiller B.W., Barbieri J.T., Lacy D.B. Structural analysis of botulinum neurotoxin type G receptor binding. Biochemistry 2010, 49:5200-5205.
23. Jin R., Rummel A., Binz T., Brunger A.T. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 2006, 444:1092-1095.
24. Chai Q., Arndt J.W., Dong M., Tepp W.H., Johnson E.A., Chapman E.R., Stevens R.C. Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 2006, 444:1096-1100.
25. Stenmark P., Dupuy J., Imamura A., Kiso M., Stevens R.C. Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog. 2008, 4:e1000129.
26. Panjikar S., Parthasarathy V., Lamzin V.S., Weiss M.S., Tucker P.A. Auto-rickshaw: an automated crystal structure determination platform as an efficient tool for the validation of an X-ray diffraction experiment. Acta Crystallogr. D Biol. Crystallogr. 2005, 61:449-457.
27. Swaminathan S., Eswaramoorthy S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 2000, 7:693-699.
28. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2126-2132.
29. Adams P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., Echols N., Headd J.J., Hung L.W., Kapral G.J., Grosse-Kunstleve R.W., McCoy A.J., Moriarty N.W., Oeffner R., Read R.J., Richardson D.C., Richardson J.S., Terwilliger T.C., Zwart P.H. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:213-221.
30. Chen V.B., Arendall W.B., Headd J.J., Keedy D.A., Immormino R.M., Kapral G.J., Murray L.W., Richardson J.S., Richardson D.C. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:12-21.
31. Strotmeier J., Lee K., Volker A.K., Mahrhold S., Zong Y., Zeiser J., Zhou J., Pich A., Bigalke H., Binz T., Rummel A., Jin R. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside dependent manner. Biochem. J. 2010, 431:207-216.
32. Karalewitz A.P., Kroken A.R., Fu Z., Baldwin M.R., Kim J.J., Barbieri J.T. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA. Biochemistry 2010, 49:8117-8126.